CAPTRUST Financial Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $206K | Sell |
5,734
-838
| -13% | -$30.2K | ﹤0.01% | 2289 |
|
|
2025
Q1 | $259K | Sell |
6,572
-990
| -13% | -$39K | ﹤0.01% | 2020 |
|
|
2024
Q4 | $228K | Sell |
7,562
-22,765
| -75% | -$685K | ﹤0.01% | 2080 |
|
|
2024
Q3 | $709K | Buy |
30,327
+5,279
| +21% | +$123K | ﹤0.01% | 1404 |
|
|
2024
Q2 | $446K | Buy |
25,048
+351
| +1% | +$6.24K | ﹤0.01% | 1568 |
|
|
2024
Q1 | $376K | Sell |
24,697
-5,651
| -19% | -$86K | ﹤0.01% | 1647 |
|
|
2023
Q4 | $518K | Buy |
30,348
+5,588
| +23% | +$95.4K | ﹤0.01% | 1713 |
|
|
2023
Q3 | $207K | Sell |
24,760
-1,782
| -7% | -$14.9K | ﹤0.01% | 2269 |
|
|
2023
Q2 | $659K | Buy |
26,542
+629
| +2% | +$15.6K | ﹤0.01% | 1473 |
|
|
2023
Q1 | $390K | Buy |
25,913
+2,854
| +12% | +$42.9K | ﹤0.01% | 1550 |
|
|
2022
Q4 | $273K | Buy |
23,059
+194
| +0.8% | +$2.3K | ﹤0.01% | 1734 |
|
|
2022
Q3 | $135K | Buy |
22,865
+22,600
| +8,528% | +$133K | ﹤0.01% | 1895 |
|
|
2022
Q2 | $1K | Sell |
265
-147
| -36% | -$555 | ﹤0.01% | 4752 |
|
|
2022
Q1 | $4K | Buy |
412
+312
| +312% | +$3.03K | ﹤0.01% | 4278 |
|
|
2021
Q4 | $2K | Sell |
100
-11
| -10% | -$220 | ﹤0.01% | 4451 |
|
|
2021
Q3 | $4K | Sell |
111
-8
| -7% | -$288 | ﹤0.01% | 4054 |
|
|
2021
Q2 | $5K | Sell |
119
-6
| -5% | -$252 | ﹤0.01% | 3879 |
|
|
2021
Q1 | $6K | Sell |
125
-760
| -86% | -$36.5K | ﹤0.01% | 3674 |
|
|
2020
Q4 | $46K | Sell |
885
-50
| -5% | -$2.6K | ﹤0.01% | 1874 |
|
|
2020
Q3 | $25K | Buy |
935
+200
| +27% | +$5.35K | ﹤0.01% | 1884 |
|
|
2020
Q2 | $15K | Buy |
+735
| New | +$15K | ﹤0.01% | 2057 |
|
|
2019
Q4 | – | Sell |
-600
| Closed | -$3K | – | 1733 |
|
|
2019
Q3 | $3K | Hold |
600
| – | – | ﹤0.01% | 1754 |
|
|
2019
Q2 | $5K | Hold |
600
| – | – | ﹤0.01% | 1656 |
|
|
2019
Q1 | $5K | Buy |
+600
| New | +$5K | ﹤0.01% | 1541 |
|